UK Takes World’s First Step Toward Omicron-Tailored Shot (1)

Aug. 15, 2022, 12:43 PM UTC

The UK has granted the world’s first approval for a Covid-19 vaccine targeting a variant in a bid to sharpen its response to an evolving coronavirus.

The country’s Medicines and Healthcare products Regulatory Agency cleared Moderna Inc.’s bivalent mRNA booster vaccine for adults, according to a statement Monday, in a move paving the way for it to potentially form part of Britain’s autumn booster campaign.

Moderna’s bivalent shot targets two strains - half of the dose works against the original version of the coronavirus, while the other half protects against BA.1, an early version of the omicron variant that fueled ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.